Navigation Links
High-nutrition and disease-resistant purple and yellow-fleshed potato clones obtained
Date:4/24/2013

The Basque Institute for Agricultural Research and Development, Neiker-Tecnalia, has created four new potato clones which are characterised by their high antioxidant content, their good production both in size and number of tubers, as well as by their resistance to the usual diseases of this crop. The clones were obtained by natural methods through crossing varieties from South America with commercial varieties used in Europe. The result was three clones of the purple-fleshed potato and one with a markedly yellow flesh. The attractiveness and nutritional value of these types of potato make them a product highly regarded by professionals in gastronomy and by the public in general.

The work of creating the clones is part of the Potato Genetic Enhancement Programme drawn up by Neiker-Tecnalia. The research was led by agricultural engineer Ms Raquel Lpez, being the basis for her PhD thesis, and was presented at the University of the Basque Country. The aim of this specialist was to find potatoes which brought together the features of the South American varieties (their colour, resistance to pathogens and their nutritional and organoleptic properties) with those of the commercial varieties employed in our latitudes and characterized by their high productivity.

The Neiker-Tecnalia researchers brought 37 varieties from the Centro Internacional de la Papa, based in Peru. These native South American varieties were crossed in the greenhouse with commercial varieties, using natural procedures. The selection of and crossing between individuals with the best traits has given rise to the four clones mentioned. For the moment, these involve advanced clones and not commercial varieties, as they are not registered at the Spanish Office for Plant Varieties (OEVV in the Spanish acronym) or the European Community Plant Variety Office (CPVO). The process of registering is a long one, lasting about 15 years.

The varieties imported from Peru have a very low productivity in our latitudes, both in size and the number of tubers. Nevertheless, with the process of crossing and selection, the final clones having acceptable productivity has been achieved.

Nutritional value and resistant to pathogens

The four clones obtained are characterised by the high presence of antioxidants compounds, making them very attractive from a nutritional perspective. The three purple-flesh clones contain a large quantity of anthocyanins a highly appreciated pigment in the preparation of high added value foods , while the yellow flesh variety have carotenes essential chemical components for the diet and in greater quantities than in the usual commercial varieties.

Resistance to diseases is another of the achievements. The four clones show certain resistance to the pathogens analysed, such as the potato virus Y, as well as the Pectobacterium atrosepticum bacteria, which weaken the vegetable and considerably undermine its production.

Researcher Raquel Lpez highlights the importance of taking into account the clones achieved. "It is beneficial for European producers to have varieties of purple flesh potato that are adapted to the climatological conditions of this continent. Moreover, these varieties incorporate natural antioxidant compounds, which are nutritionally and visually attractive, both for restaurant professionals and for end consumers".


'/>"/>

Contact: Irati Kortabitarte
i.kortabitarte@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Related biology news :

1. Genome decoded: Scientists find clues to more disease-resistant watermelons
2. Purple corn compound may aid in developing future treatments for Type 2 diabetes, kidney disease
3. How the purple and pink sunscreens of reef corals work
4. Red potato chips: Segmentation cues can substantially decrease food intake
5. Team including UC Riverside entomologist honored for research leading to healthier potato chips
6. Couch potatoes may be genetically predisposed to being lazy, MU study finds
7. Just a few cell clones can make heart muscle
8. Ants farm root aphid clones in subterranean rooms
9. Melon genome obtained
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2017)... SAN MATEO, Calif. , March 6, 2017 ... predictive marketing and sales technology, today announced Predictive ... (AI) solution for infusing actionable sales intelligence into ... customers to automatically enable their sales organizations with ... contextual messages that allow for intelligent engagement. Predictive ...
(Date:3/2/2017)... 2017 Summary This report provides ... KGaA and its partnering interests and activities since 2010. ... Description The Partnering Deals and Alliance since 2010 report ... one of the world,s leading life sciences companies. ... to ensure inclusion of the most up to date ...
(Date:3/2/2017)... Australia , March 2, 2017 Australian ... Ltd (ASX: CYP), has signed an agreement with ... from the Monash Biomedicine Discovery Institute and Department of ... to conduct a further preclinical study to support the ... treatment of asthma.  Asthma is a ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... ... March 28, 2017 , ... Executive search firm, Slone ... Analytical Services. Harvill is a distinguished life sciences expert with a proven track ... leader in a wide range of services related to laboratory testing and analysis ...
(Date:3/27/2017)... Infectex Ltd., a Russian portfolio company of Maxwell Biotech Venture ... added to the standard drug therapy regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). ... USA ) and the US National Institutes of Health. ... ... Logo ...
(Date:3/27/2017)... ... March 27, 2017 , ... A research team ... vascular grafts in JoVE’s Video Journal, the world’s first peer-reviewed scientific video journal. ... of treating coronary artery disease (CAD). Lam is an assistant professor at the ...
(Date:3/24/2017)... and ROCKVILLE, Md. , March ... of Maxwell Biotech Venture Fund (MBVF), today announced positive ... added to the standard drug therapy regimen in patients ... small molecule drug discovered by scientists at Sequella, Inc. ... Institutes of Health. A total of ...
Breaking Biology Technology: